Production (Stage)
IGC Pharma, Inc.
IGC
$0.3441
$0.00451.33%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 58.51% | 67.28% | 29.95% | -14.60% | 28.41% |
| Total Depreciation and Amortization | -6.10% | -1.88% | -8.23% | 4.52% | 7.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.89% | -90.22% | -29.58% | 32.24% | -26.52% |
| Change in Net Operating Assets | -117.68% | 50.00% | 51.61% | -58.11% | 1.39% |
| Cash from Operations | -38.78% | 17.01% | 38.44% | -19.35% | 65.33% |
| Capital Expenditure | -20.00% | 60.29% | 17.14% | -90.00% | -200.00% |
| Sale of Property, Plant, and Equipment | 1,100.00% | -- | 1,700.00% | -- | 133.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.26% | -1,200.00% | -148.15% | -232.14% | -34.20% |
| Cash from Investing | 56.04% | -70.49% | -190.28% | -2,520.00% | -33.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00% | 0.00% | 0.00% | 100.00% |
| Issuance of Common Stock | 20.69% | -- | -72.20% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 20.69% | 34,600.00% | -72.23% | 250,800.00% | 66,800.00% |
| Foreign Exchange rate Adjustments | 0.00% | -100.00% | -10.00% | 100.00% | -81.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.89% | 34.71% | -121.34% | 142.50% | 89.71% |